Bausch Health (BHC) | Financial Analysis & Statements
Bausch Health Companies Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
2.8B
Gross Profit
2.0B
71.46%
Operating Income
829.0M
29.65%
Net Income
-103.0M
-3.68%
EPS (Diluted)
$-0.30
Balance Sheet Metrics
Total Assets
26.4B
Total Liabilities
26.0B
Shareholders Equity
377.0M
Debt to Equity
68.94
Cash Flow Metrics
Operating Cash Flow
548.0M
Free Cash Flow
403.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Bausch Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.3B | 9.6B | 8.8B | 8.1B | 8.4B |
| Cost of Goods Sold | 3.0B | 2.8B | 2.6B | 2.4B | 2.4B |
| Gross Profit | 7.3B | 6.8B | 6.2B | 5.8B | 6.0B |
| Gross Margin % | 70.7% | 71.1% | 70.8% | 70.9% | 71.6% |
| Operating Expenses | |||||
| Research & Development | 629.0M | 616.0M | 604.0M | 530.0M | 473.0M |
| Selling, General & Administrative | 3.4B | 3.3B | 2.9B | 2.6B | 2.6B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 4.1B | 3.9B | 3.5B | 3.2B | 3.1B |
| Operating Income | 2.2B | 1.9B | 1.6B | 1.4B | 1.6B |
| Operating Margin % | 21.3% | 19.3% | 18.3% | 17.1% | 18.6% |
| Non-Operating Items | |||||
| Interest Income | 48.0M | 33.0M | 26.0M | 14.0M | 7.0M |
| Interest Expense | 1.6B | 1.4B | 1.3B | 1.5B | 1.4B |
| Other Non-Operating Income | -262.0M | -332.0M | -688.0M | -69.0M | -1.2B |
| Pre-tax Income | 367.0M | 167.0M | -390.0M | -129.0M | -1.0B |
| Income Tax | 247.0M | 239.0M | 221.0M | 83.0M | -87.0M |
| Effective Tax Rate % | 67.3% | 143.1% | 0.0% | 0.0% | 0.0% |
| Net Income | 120.0M | -72.0M | -611.0M | -212.0M | -937.0M |
| Net Margin % | 1.2% | -0.7% | -7.0% | -2.6% | -11.1% |
| Key Metrics | |||||
| EBITDA | 3.4B | 3.2B | 2.9B | 2.8B | 3.1B |
| EPS (Basic) | - | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| EPS (Diluted) | - | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Basic Shares Outstanding | - | 353846154 | 365432099 | 362903226 | 359405748 |
| Diluted Shares Outstanding | - | 353846154 | 365432099 | 362903226 | 359405748 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Bausch Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.3B | 1.2B | 947.0M | 564.0M | 582.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 2.4B | 2.1B | 2.0B | 1.8B | 1.8B |
| Inventory | 1.6B | 1.6B | 1.5B | 1.1B | 993.0M |
| Other Current Assets | 852.0M | 838.0M | 1.1B | 776.0M | 720.0M |
| Total Current Assets | 6.2B | 5.8B | 5.6B | 4.2B | 5.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 112.0M | 97.0M | 84.0M | 78.0M | 73.0M |
| Goodwill | 27.2B | 27.7B | 28.8B | 28.9B | 31.9B |
| Intangible Assets | 4.6B | 5.6B | 6.5B | 5.8B | 6.9B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.2B | 2.3B | 2.4B | 2.5B | 2.6B |
| Total Non-Current Assets | 20.2B | 20.7B | 21.8B | 21.4B | 23.6B |
| Total Assets | 26.4B | 26.5B | 27.4B | 25.7B | 29.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 600.0M | 656.0M | 719.0M | 521.0M | 407.0M |
| Short-term Debt | 236.0M | 2.7B | 450.0M | 432.0M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 999.0M | 1.0B | 1.0B | 1.0B | 2.6B |
| Total Current Liabilities | 4.2B | 6.8B | 4.3B | 3.9B | 5.2B |
| Non-Current Liabilities | |||||
| Long-term Debt | 20.6B | 18.9B | 21.9B | 20.3B | 22.7B |
| Deferred Tax Liabilities | 147.0M | 128.0M | 163.0M | 202.0M | 529.0M |
| Other Non-Current Liabilities | 1.0B | 1.0B | 1.0B | 949.0M | 855.0M |
| Total Non-Current Liabilities | 21.8B | 20.1B | 23.1B | 21.5B | 24.0B |
| Total Liabilities | 26.0B | 26.8B | 27.4B | 25.4B | 29.2B |
| Equity | |||||
| Common Stock | 10.5B | 10.5B | 10.4B | 10.4B | 10.3B |
| Retained Earnings | -9.7B | -9.8B | -9.8B | -9.2B | -9.0B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 377.0M | -322.0M | -82.0M | 260.0M | -34.0M |
| Key Metrics | |||||
| Total Debt | 20.9B | 21.6B | 22.4B | 20.8B | 22.7B |
| Working Capital | 2.0B | -978.0M | 1.3B | 306.0M | 409.0M |
Balance Sheet Composition
Bausch Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 120.0M | -72.0M | -611.0M | -212.0M | -937.0M |
| Depreciation & Amortization | 1.2B | 1.3B | 1.3B | 1.4B | 1.6B |
| Stock-Based Compensation | 216.0M | 150.0M | 132.0M | 126.0M | 128.0M |
| Working Capital Changes | -222.0M | -126.0M | -359.0M | -330.0M | -124.0M |
| Operating Cash Flow | 1.4B | 1.4B | 628.0M | -669.0M | 662.0M |
| Investing Activities | |||||
| Capital Expenditures | -397.0M | -337.0M | -215.0M | -218.0M | -269.0M |
| Acquisitions | -204.0M | -136.0M | -1.9B | -45.0M | 0 |
| Investment Purchases | -11.0M | -12.0M | -27.0M | -17.0M | -19.0M |
| Investment Sales | 8.0M | 14.0M | 26.0M | 22.0M | 15.0M |
| Investing Cash Flow | -597.0M | -464.0M | -2.1B | -253.0M | 396.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 10.6B | 661.0M | 3.3B | 6.8B | 2.1B |
| Debt Repayment | -11.2B | -1.5B | -1.7B | -7.8B | -3.4B |
| Financing Cash Flow | -742.0M | -868.0M | 1.5B | -474.0M | -1.5B |
| Free Cash Flow | 993.0M | 1.3B | 760.0M | -996.0M | 1.1B |
| Net Change in Cash | 23.0M | 84.0M | 2.0M | -1.4B | -455.0M |
Cash Flow Trend
Bausch Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.19
Forward P/E
1.37
Price to Book
5.58
Price to Sales
0.20
PEG Ratio
-0.06
Profitability Ratios
Profit Margin
1.53%
Operating Margin
25.79%
Return on Equity
436.36%
Return on Assets
5.18%
Financial Health
Current Ratio
1.47
Debt to Equity
5,591.25
Beta
0.40
Per Share Data
EPS (TTM)
$0.42
Book Value per Share
$-1.50
Revenue per Share
$27.68
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BHC | 2.1B | 13.19 | 5.58 | 436.36% | 1.53% | 5,591.25 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Alkermes plc | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Lantheus Holdings | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






